Ignite Creation Date:
2024-05-06 @ 1:46 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04123470
Status:
COMPLETED
Last Update Posted:
2023-08-29
First Post:
2019-10-09
Brief Title:
A Phase III Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Sponsor:
Organization:
Lokon Pharma AB